Vaccine trials for children younger than 12 years old could start early next year, Dr. Francis Collins, the director of the US National Institutes of Health, said Wednesday.
We “very definitely need to get there,” Collins told CNN’s Wolf Blitzer, because only children 12 and older are being studied right now.
“We will want to, shortly after the first of the year, also find out does this work for younger children because we know they can be infected and they can pass this along,” he said.
“So that is a next sort of level of test that's going to need to be done in a … vaccine trial in order to be sure that the vaccine is safe and effective in that group."
Pfizer and Moderna are now testing their respective vaccines on children between 12 and 18 years old.
Both Pfizer’s and Moderna’s vaccines are expected to receive an emergency use authorization in the US for adults in the near future. Pfizer received emergency authorization for its vaccine in the United Kingdom on Wednesday.